Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Ifosfamide-induced extrapyramidal neurotoxicity with COVID-19
Chitrakshi Nagpal
, Ayush Agarwal
, Vineeta Venkateswaran
, Kapil Soni
, M. V. Srivastava
,
Anjan Trikha
Department of Anesthesiology and Perioperative Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ifosfamide-induced extrapyramidal neurotoxicity with COVID-19'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Neurotoxicity
100%
COVID-19
100%
Ifosfamide
100%
Antiinfective Agent
25%
Solid Malignant Neoplasm
25%
Coma
25%
Infusion
25%
Sequela
25%
Epileptic Seizure
25%
Blurred Vision
25%
Cyclophosphamide
25%
Drug Administration
25%
Phyllodes Tumor
25%
Brain Imaging
25%
Mutism
25%
Hallucination
25%
Delirium
25%
Diseases
25%
Connective Tissue Cancer
25%
Extrapyramidal Symptom
25%
Diagnosis of Exclusion
25%
Stupor
25%
Side Effect
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neurotoxicity
100%
Ifosfamide
100%
Solid Malignant Neoplasm
25%
Antiinfective Agent
25%
Delirium
25%
Drug Administration
25%
Cyclophosphamide
25%
Coma
25%
Extrapyramidal Symptoms
25%
Phyllodes Tumor
25%
Hallucination
25%
Stupor
25%
Diseases
25%
Connective Tissue Cancer
25%
Blurred Vision
25%
Side Effect
25%
Keyphrases
Visual Blurring
25%
Phyllodes Tumor
25%
Rare Side Effect
25%